Tirtha Chakraborty - May 1, 2025 Form 4 Insider Report for Vor Biopharma Inc. (VOR)

Role
Chief Sci Off & Head Tech Ops
Signature
/s/ Katie Kazem, Attorney-in-Fact
Stock symbol
VOR
Transactions as of
May 1, 2025
Transactions value $
-$1,285
Form type
4
Date filed
5/2/2025, 04:29 PM
Previous filing
Feb 7, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Chakraborty Tirtha Chief Sci Off & Head Tech Ops C/O VOR BIOPHARMA INC., 100 CAMBRIDGEPARK DRIVE, SUITE 101, CAMBRIDGE /s/ Katie Kazem, Attorney-in-Fact 2025-05-02 0001840685

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VOR Common Stock Tax liability -$650 -985 -0.45% $0.66 219K May 1, 2025 Direct F1
transaction VOR Common Stock Tax liability -$635 -962 -0.44% $0.66 218K May 1, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units.